Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

Summary

This is a phase 1, randomized, open label, single-dose, replicate crossover clinical trial to compare the safety and pharmacokinetics of YH22162 in healthy male volunteers. Hypothesis: Study drug and comparator drug are showing equal pharmacokinetics.

Timeline

Start

2018-10-05

Primary completion

2018-12-08

Completion

2018-12-22

Drugs

Indications